ASMI says OTC analgesics effective for short term pain relief
12 June 2014 - The Australian Self Medication Industry (ASMI) today reassured consumers that analgesics available over-the-counter have an established safety profile and are effective for short term relief of pain.
This was in response to media coverage suggesting Australian consumers are being misled about the claims made in relation to over-the-counter (OTC) analgesics. 1
ASMI Director of Regulatory and Scientific Affairs Steve Scarff
said: "OTC analgesics are approved by the Therapeutic Goods
Administration (TGA) after a rigorous review process.
"There are strict controls on safety, efficacy, labelling, packaging and the promotion of these medicines.
"There is a review mechanism for all advertising of these products.
"Consumers are free to choose the version of a medicine that
they purchase. They should carefully follow the instructions on the
label and if they have any concerns about a medicine they should
consult with their GP or pharmacist," said Mr Scarff.
About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy. www.asmi.com.au
1. The truth about your painkillers: Is Panadol Rapid actually rapid? news.com.au, http://www.news.com.au/lifestyle/health/the-truth-about-your-painkillers-is-panadol-rapid-actually-rapid/story-fneuzlbd-1226951299215.0
For more information or to arrange a media interview, please
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: email@example.com